Skip to Content
Merck
  • The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.

The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.

Biochimica et biophysica acta (1996-10-07)
M Mikhaylova, G Wiederschain, V Mikhaylov, J M Aerts
ABSTRACT

Fluorogenic 6-acylamino-4-methylumbelliferyl-beta-D-glucosides were found to be poor substrates for the three known human beta-glucosidases, i.e., lysosomal and non-lysosomal glucocerebrosidases and cytosolic broad-specificity beta-glucosidase. However, homogenates of human tissues and human cell types showed significant enzymatic hydrolysis of 6-ethanoylamino-4-methylumbelliferyl-beta-D-glucoside (EMGlc) due to the activity of a hitherto undescribed beta-glucosidase, called here EMGlc-ase. It was shown that the isozyme is hardly active towards 4-methylumbelliferyl-beta-D-glucoside or glucosylceramide. EMGlc-ase exhibits maximal activity at pH 4.5 and 5.0 in the absence and presence of sodium taurocholate respectively. It is a soluble lysosomal enzyme with a discrete isoelectric point of about 5.0. EMGlc-ase is not inhibited by conduritol B-epoxide, is activated by sodium taurocholate and binds strongly to Concanavalin A. This enzyme is not deficient in relation to Gaucher disease.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4-Methylumbelliferyl α-D-glucopyranoside, ≥98% (TLC)
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
4-Methylumbelliferyl α-D-glucopyranoside, α-glucosidase substrate
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
4-Methylumbelliferyl β-D-glucopyranoside, β-glucosidase substrate
SKU
Pack Size
Availability
Price
Quantity